Thorough QT/QTc study of Staccato prochlorperazine for inhalation in healthy volunteers

Trial Profile

Thorough QT/QTc study of Staccato prochlorperazine for inhalation in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs Prochlorperazine (Primary) ; Moxifloxacin
  • Indications Bacterial infections; Migraine
  • Focus Pharmacodynamics
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 23 Jan 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Nov 2007 The expected completion date for this trial is now 31 Mar 2008.
    • 24 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top